• Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, said its U.S. subsidiary entered a deal with Caraco Pharmaceutical Laboratories Ltd., a subsidiary of Mumbai, India-based Sun Pharmaceutical Industries Ltd. for the sale of the non-Colcrys (colchicine, USP), generic business of URL Pharma Inc.